Prospective evaluation of the contribution of K-ras mutational analysis and CA 19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer
- 1 October 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (16) , 2069-2075
- https://doi.org/10.1016/s0959-8049(00)00288-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Detection of K-ras Point Mutations at Codon 12 in Pure Pancreatic Juice for the Diagnosis of Pancreatic Cancer by PCR-RFLP AnalysisPancreas, 1996
- Identification of K-ras Mutations in Pancreatic Juice in the Early Diagnosis of Pancreatic CancerAnnals of Internal Medicine, 1995
- Ki-ras Mutations in Pancreatic Secretions and Aspirates From Two Patients Without Pancreatic CancerJNCI Journal of the National Cancer Institute, 1994
- Diagnosis of pancreatic adenocarcinoma by polymerase chain reaction from pancreatic secretionsBritish Journal of Cancer, 1994
- Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinomaCancer, 1994
- Pancreatic biopsy: striving for excellence.Radiology, 1993
- Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. The endoscopic retrograde intraductal catheter aspiration cytologic techniqueCancer, 1992
- Ki-ras oncogene activation in preinvasive pancreatic cancerGastroenterology, 1992
- Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinomaGastroenterology, 1991
- Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancerBritish Journal of Cancer, 1986